Liabilities / Assets
76th percentile
Higher debt load relative to assets than 76% of similar nonprofits.
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
76th percentile
Higher debt load relative to assets than 76% of similar nonprofits.
Liabilities / Revenue
88th percentile
Higher debt load relative to revenue than 88% of similar nonprofits.
Net Margin
64th percentile
Higher net margin than 64% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
62nd percentile
Faster asset growth than 62% of similar nonprofits.
Revenue Growth
16th percentile
Faster revenue growth than 16% of similar nonprofits.
Assets
Up$3,418,875
Up $136,724 (+4.2%) from 2014
Net Assets
Up$2,159,997
Up $246,102 (+13%) from 2014
Liabilities
Down$1,258,878
Down $109,378 (-8.0%) from 2014
Revenue
Down$2,720,423
Down $582,113 (-18%) from 2014
Expenses
Down$2,474,850
Down $690,428 (-22%) from 2014
Net Income
Up$245,573
Up $108,315 (+79%) from 2014
This 2015 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Curepsp is a nonprofit advocacy organization focused on prime of life neurodegenerative diseases, a spectrum of fatal brain disorders that often strike during middle age. Since it was founded in 1990, cure psp has provided signficant support for scientists, patients and families, and healthcare professionals. Because of its focus on tau protein-related diseases like progressive supranuclear palsy (psp), curepsp occupies a central position in current neurodegeneration research through its funding of talented early career investigators and its abiility to recruit for and market clincal trials in psp now being undertaken by major pharmaceutical manufacturers.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2015 • Form 990Summary only. Only limited summary data is available for this year.